Colorectal Cancer Treatments
Find Colorectal Cancer Treatments
Erbitux
What is Erbitux (Cetuximab)?
Approved To Treat
Top Global Experts
Related Clinical Trials
Background: Myeloid cells are a type of immune cell found in most tumors. Interleukin 12 (IL-12) is a protein that helps the immune system kill tumor cells. Researchers want to know if myeloid cells that have been genetically engineered to produce IL-12 (IL-12 GEMys) can activate the immune system to attack cancer cells in solid tumors.
Summary: This phase III trial compares cetuximab to chemotherapy, carboplatin and paclitaxel, with intensity modulated radiation therapy for the treatment of patients with head and neck cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) who are unable to receive cisplatin. Cetuximab is in a class of medications called monoclonal an...
Summary: This phase II, single-arm clinical study aims to evaluate the efficacy and safety of toripalimab combined with cetuximab and irinotecan as second-line treatment for patients with advanced right-sided colon cancer with wild-type RAS and BRAF genes. The study will enroll up to 46 adult patients with recurrent or metastatic right-sided colon cancer whose disease has progressed after first-line system...
Related Latest Advances
Brand Information
- Infusion reactions
- Cardiopulmonary arrest
- Pulmonary toxicity
- Dermatologic toxicity
- Hypomagnesemia and Electrolyte Abnormalities
- Neurologic: Aseptic meningitis
- Gastrointestinal: Mucosal inflammation
- Dermatologic: Stevens-Johnson syndrome, toxic epidermal necrolysis, life-threatening and fatal bullous mucocutaneous disease

